CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED 2 of 17 • "Facility" means Lonza's...Commercial Manufacturing Services and Supply Agreement • August 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • New York
ContractManufacturing and Supply Agreement • August 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED 2 Copy to: [***] Copy to: [***]...Commercial Manufacturing Services and Supply Agreement • August 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations
